Abstract:Oncogenesis in breast cancer often requires the overexpression of the nuclear receptor coactivator AIB1/SRC-3 acting in conjunction with estrogen receptor-alpha (ERalpha). Phosphorylation of both ERalpha and AIB1 has been shown to have profound effects on their functions. In addition, proteasome-mediated degradation plays a major role by regulating their stability and activity. CK1delta, a member of the ubiquitous casein kinase-1 family, is implicated in the progression of breast cancer. In this study, we show that both ERalpha and AIB1 are substrates for CK1delta in vitro, and identify a novel AIB1 phosphorylation site (S601) targeted by CK1delta, significant for the co-activator function of AIB1. CK1delta is able to interact with ERalpha and AIB1 in vivo, while overexpression of CK1delta in breast cancer cells results in an increased association of ERalpha with AIB1 as confirmed by co-immunoprecipitation assays from cell lysates. Using an siRNA-based approach, luciferase reporter assays and qRT-PCR, we observe that silencing of CK1delta leads to reduced ERalpha transcriptional activity, despite increased ERalpha levels, similarly to proteasome inhibition. We provide evidence that AIB1 protein levels are reduced by CK1delta silencing, in an estradiol-dependent manner; such destabilization can be inhibited by pre-treatment with the proteasome inhibitor MG132. We propose that differing activities adopted by ERalpha and AIB1 as a consequence of their interactions with and phosphorylation by CK1delta, particularly AIB1 stabilization, influence the transcriptional activity of ERalpha, and therefore have a role in breast cancer development.

CK1δ Activity is Modulated by CDK2/E- and CDK5/p35-mediated Phosphorylation

CK1δ Kinase Activity is Modulated by Protein Kinase C Α (Pkcα)-Mediated Site-Specific Phosphorylation.

Kinase Activity of Casein Kinase 1 Delta (ck1δ) is Modulated by Protein Kinase C Α (pkcα) by Site-Specific Phosphorylation Within the Kinase Domain of CK1δ

Effects of Altered Expression and Activity Levels of CK1δ and Ɛ on Tumor Growth and Survival of Colorectal Cancer Patients

Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines

Structure, Regulation, and (Patho-)Physiological Functions of the Stress-Induced Protein Kinase CK1 Delta (CSNK1D).

CK1δ in Lymphoma: Gene Expression and Mutation Analyses and Validation of CK1δ Kinase Activity for Therapeutic Application.

Molecular basis for the regulation of the circadian clock kinases CK1δ and CK1ε

The CK1 Family: Contribution to Cellular Stress Response and Its Role in Carcinogenesis

Isoform-specific C-terminal phosphorylation drives autoinhibition of Casein Kinase 1

Casein kinase 1α: biological mechanisms and theranostic potential

CK1δ/ε inhibition induces ULK1-mediated autophagy in tumorigenesis

Ckip-1: A Scaffold Protein and Potential Therapeutic Target Integrating Multiple Signaling Pathways and Physiological Functions

Inhibition of CK1ε Potentiates the Therapeutic Efficacy of CDK4/6 Inhibitor in Breast Cancer

Small Molecule Modulators Targeting Protein Kinase CK1 and CK2

KNOCKDOWN OF CASEIN KINASE 1e INHIBITS CELL PROLIFERATION AND INVASION OF COLORECTAL CANCER CELLS VIA INHIBITION OF THE Wnt/β-CATENIN SIGNALING.

Kinase domain autophosphorylation rewires the activity and substrate specificity of CK1 enzymes

Physiological and pathological roles of the transcriptional kinases CDK12 and CDK13 in the central nervous system

Retracted: CK1δ Modulates the Transcriptional Activity of ERα Via AIB1 in an Estrogen-Dependent Manner and Regulates ERα–AIB1 Interactions

KNOCKDOWN OF CASEIN KINASE le INHIBITS CELL PROLIFERATION AND INVASION OF COLORECTAL CANCER CELLS VIA INHIBITION OF THE Wnt/beta-CATENIN SIGNALING

Investigating the neuroprotective mechanism of action of a CDK5 inhibitor by phosphoproteome analysis